📊 Evidence-Based Reference

Sis Fistula Plug

Cook Biotech

Compare similar devices

Summary: The SIS fistula plug by Cook Biotech is a bioprosthetic device used for treating fistulas. Key evidence suggests its effectiveness in closing fistulas with a low recurrence rate.

FDA Clearance Information

Pathway ? 510(k)
Number ? K050337 ↗
Decision Date ? March 9, 2005
Product Code ? FTM
Device Class ? Class 2
Evidence ? 0 studies

The SIS fistula plug was cleared by the FDA through the 510(k) pathway on March 9, 2005. It is manufactured by Cook Biotech and classified as a Class 2 device.

What It Is

The SIS fistula plug is a bioprosthetic device made from porcine small intestinal submucosa. It is designed to promote tissue integration and healing in the treatment of fistulas.

FDA-Cleared Indications

  • Use as a surgical mesh for the repair of soft-tissue defects.
  • Use in the repair of fistulas when clinically appropriate.
  • The FDA clearance is a Class II 510(k) clearance under product code FTM; the specific indication should be confirmed in the current manufacturer labeling.

Clinical Applications

  • Repair of selected anal or anorectal fistulas.
  • Repair of selected enterocutaneous fistulas.
  • Repair of selected gastrointestinal fistulas.
  • Use as a biologic scaffold during surgical fistula closure.

Reported off-label uses

  • Repair of selected tracheoesophageal fistulas has been described in clinical practice and published reports, but this use should not be assumed to be FDA-labeled and requires specialist judgment.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The literature includes six studies ranging from 2013 to 2024, comprising case reports and trials. These studies explore the use of SIS plugs in various fistula types.

Reported Outcomes

Published studies report successful fistula closure in a majority of cases, with a recurrence rate of approximately 33% in some studies. The device has shown efficacy in both anal and enterocutaneous fistulas.

Safety Profile

Reported complications include fistula recurrence in some patients, with no significant adverse events directly attributed to the device itself.

Evidence Limitations

The evidence is limited by small sample sizes and a lack of long-term follow-up data. Further research is needed to establish long-term efficacy and safety.

Practical Considerations

  • The device is derived from porcine small intestinal submucosa; assess for relevant allergies, religious or cultural concerns, and informed consent requirements.
  • Size and configuration must match the fistula tract and surrounding tissue; adequate drainage and control of infection are generally important before closure.
  • The plug is a biologic scaffold intended for tissue integration and is not a permanent metallic implant. Handling and placement should follow the current instructions for use.
  • MRI safety should be confirmed in the current manufacturer labeling. A biologic, nonmetallic implant is generally not expected to create the same MRI hazards as a metallic device, but the exact labeling controls.
  • Contraindications and precautions include uncontrolled infection, inadequate tissue quality, active inflammation that has not been treated, or inability to identify and manage the fistula source.

Frequently Asked Questions

What are the clinical indications for SIS fistula plug?

The SIS fistula plug is indicated for the treatment of anal, enterocutaneous, and tracheo-esophageal fistulas.

What outcomes have been reported in clinical studies?

Studies have reported successful closure of fistulas with a recurrence rate of about 33% in some cases.

What complications have been reported?

Reported complications include fistula recurrence, with no major adverse events directly linked to the device.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you